Preclinical Pharmacokinetics and In Vitro Metabolism of BMS-605339: A Novel HCV NS3 Protease Inhibitor
Version of Record online: 3 APR 2014
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association
Journal of Pharmaceutical Sciences
Volume 103, Issue 6, pages 1891–1902, June 2014
How to Cite
Jenkins, S., Scola, P., McPhee, F., Knipe, J., Gesenberg, C., Sinz, M., Arora, V., Pilcher, G. and Santone, K. (2014), Preclinical Pharmacokinetics and In Vitro Metabolism of BMS-605339: A Novel HCV NS3 Protease Inhibitor. J. Pharm. Sci., 103: 1891–1902. doi: 10.1002/jps.23959
- Issue online: 20 MAY 2014
- Version of Record online: 3 APR 2014
- Manuscript Accepted: 6 MAR 2014
- Manuscript Revised: 4 MAR 2014
- Manuscript Received: 12 JAN 2014
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!